Health TrialsbyHealthPanel

Bufei Recipe Reduces the Incidence Rate of COPD

ConditionPreserved Ratio Impaired Spirometry
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHenan University of Traditional Chinese Medicine

About this trial

Establish early TCM prevention and treatment program to reduce the incidence rate of COPD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

smoking history (including previous and current smokers);

1 year or more of exposure to dust or chemical toxins;

Indoor air pollution for 1 year or more (use of contaminated fuels, passive smoking, exposure) Oil fumes, etc.

Cough (more than 3 months per year, continuous for 2 years or more);

Disqualifiers

Pregnant and planned pregnancy, lactating women.

Dementia and various mental illness patients.

Other diseases with chronic cough, sputum production, or difficulty breathing.

Merge tumors.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bufei Recipe

    Drug

    Bufei Recipe: Roasted Astragalus, Codonopsis pilosula, Walnut kernels, Sichuan Fritillaria, Angelica sinensis, Stir fried Purple Su Zi, Honey Baibu, Roasted Purple Aster, etc. Take 1 dose daily, 5 days a week.

  • Bufei Recipe placebo

    Drug

    The placebo was prepared using 5% of the drug, with color, odor, taste, appearance, and weight similar to the experimental group drug, and packaging consistent with the experimental group drug.

Treatment groups

1,100 Participants
are divided into 2 treatment groups
Group A: Bufei RecipeExperimental treatment 1 intervention
Group B: Bufei Recipe placeboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence rate of COPD

Incidence rate of COPD

Time frame
Change from baseline in the number of people with COPD at month 24.

Secondary outcomes

1

FVC

Forced Vital Capacity (FVC) was mainly used for lung function evaluation

Time frame
Change from baseline in FVC at months 12 and 24.
2

FEV1

Forced Expiratory Volume in One Second (FEV1) was mainly used for lung function evaluation

Time frame
Change from baseline in FEV1 at months 12 and 24.
3

FEV1% pred

Percentage of Forced Expiratory Volume in One Second to Predicted Value (FEV1% pred) was mainly used for lung function evaluation

Time frame
Change from baseline in FEV1% pred at months 12 and 24.
4

FEV1/FVC

Forced Expiratory Volume in One Second / Forced Vital Capacity (FEV1/FVC) was mainly used for lung function evaluation

Time frame
Change from baseline in FEV1/FVC at months 12 and 24.

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Henan University of Traditional Chinese Medicine

Lead sponsor

West China Hospital

Collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: